RNA icon

Avidity Biosciences

142 hedge funds and large institutions have $522M invested in Avidity Biosciences in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 62 increasing their positions, 40 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

5% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 19

6.11% less ownership

Funds ownership: 116.41%110.3% (-6.1%)

43% less capital invested

Capital invested by funds: $915M → $522M (-$393M)

Holders
142
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$601K
Puts
$14K
Net Calls
Net Calls Change

Top Buyers

1 +$4.44M
2 +$3.51M
3 +$3.14M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$2.68M
5
CC
Casdin Capital
New York
+$2.55M

Top Sellers

1 -$12.9M
2 -$5.42M
3 -$4.04M
4
Bank of America
Bank of America
North Carolina
-$2.08M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$2.01M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$858K
52
$855K
53
$851K
54
$812K
55
$798K
56
$794K
57
$786K
58
$779K
59
$740K
60
$707K
61
$706K
62
$705K
63
$671K
64
$670K
65
$595K
66
$582K
67
$422K
68
$419K
69
$415K
70
$394K
71
$387K
72
$387K
73
$386K
74
$381K
75
$378K